Oracle Corporation

Analyst Ratings Synthesis

Consensus is Buy across 28 analysts. Supplied targets run from $225 to $240, while the stated mean is $242.50, which is above the stated high and therefore internally inconsistent; the disclosed numerical spread is $15. No named analyst is identified as most bullish, while Freedom Broker is the least bullish among the explicitly named actions, cutting its target to $205 from $210. Revisions were negative over the supplied period because of that reduction, and no offsetting upward revision is identified. The substantive disagreement is whether Oracle’s AI contracts and backlog justify aggressive investment and support substantial upside, or whether layoffs, heavy borrowing, credit concerns, and uncertain conversion of commitments into cash flow warrant lower targets.

• ‘Show Me the Money,’ Says Investor About Oracle Stock
• Oracle's CEO just sold $1.5 million in stock as shares rebound
• The Oracle Stock Question Wall Street Will Be Asking for Years
• The Oracle Stock Question Wall Street Will Be Asking for Years
• Our Oracle Stock Pick Is Down, But Stabilizing. Buy More.